AurĂ©lie Docquier, PhD, is Doctor of molecular and cellular biology. During her PhD at the INSERM unit 896 within the Institut de Recherche en CancĂ©rologie de Montpellier, she studied the regulation of genes involved in cell cycle progression in breast cancer and the impact of several hormones on estrogen receptors in ovarian cancer. Then, she joined INRA as a postdoc and was then appointed Preclinical Study Director at 4P-Pharma in 2014, a CRO specialized in oncology. AurĂ©lie joined OREGA Biotech in 2016 and is based in Montpellier. See AurĂ©lieâ€™s publications.